Why is TTK Healthcare falling/rising?

As of 17-Sep, TTK Healthcare Ltd. is experiencing a price increase, currently at 1,205.00, reflecting a change of 34.0 or 2.9% upward. However, the stock has underperformed its sector significantly, with a performance today that is down by 100.04%. The stock has not traded on one day out of the last 20, indicating erratic trading behavior. Additionally, TTK Healthcare is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Despite a low debt-to-equity ratio and a return on equity of 6.3, the stock's performance has been disappointing, with a year-to-date return of -14.94% and a one-year return of -29.88%. The company's profits have increased by 6.3%, but the high PEG ratio of 4 suggests that the stock may be overvalued compared to its growth.
In the broader market context, TTK Healthcare's short-term return of +4.97% over the past week outperforms the Sensex's return of +1.56%, indicating some positive momentum in the very short term. However, the stock's long-term performance has been below par, underperforming the BSE500 over the last three years, one year, and three months. The low stake held by domestic mutual funds, at only 0.17%, may reflect a lack of confidence in the company's valuation or business prospects. Overall, while there is a slight uptick in the stock price, the underlying factors suggest a challenging environment for TTK Healthcare, with significant concerns regarding its long-term viability and investor sentiment.